Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Bolsa de valores de Sao Paulo  >  Hypera    HYPE3   BRHYPEACNOR0

HYPERA

(HYPE3)
  Report
End-of-day quote. End-of-day quote Bolsa de valores de Sao Paulo - 07/03
32.4 BRL   +0.62%
06/29HYPERA : Ex-dividend day for
FA
03/30HYPERA : Ex-dividend day for
FA
03/09HYPERA : Slide show results
CO
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bolsa De Valores De Sao P…
06/29/2020 06/30/2020 07/01/2020 07/02/2020 07/03/2020 Date
33.61 33.3 33.15 32.2 32.4 Last
2127800 3205900 3779600 5314200 3427100 Volume
-0.41% -0.92% -0.45% -2.87% +0.62% Change
Financials
Sales 2020 4 195 M 791 M 791 M
Net income 2020 1 139 M 215 M 215 M
Net Debt 2020 466 M 87,9 M 87,9 M
P/E ratio 2020 17,8x
Yield 2020 3,35%
Sales 2021 4 675 M 881 M 881 M
Net income 2021 1 303 M 246 M 246 M
Net cash position 2021 1 122 M 212 M 212 M
P/E ratio 2021 15,4x
Yield 2021 3,03%
Capitalization 20 460 M 3 840 M 3 857 M
EV / Sales 2020 4,99x
EV / Sales 2021 4,14x
Nbr of Employees 7 515
Free-Float 57,7%
More Financials
Company
Hypera (formerly Hypermarcas) is the Brazilian leader in the manufacture and marketing of pharmaceutical products. The products are sold primarily under the Addera D3, Adocyl, AdultMax, Alivium, Apracur, Atroveran, Benegrip, Bigfral, Biotonico Fontoura, Coristina, Cremer, Doril, Engov, Epocler, Lisador and Neo Quimica. The activity is organized around 3 families of products : - OTC medicines; - prescription... 
More about the company
Surperformance© ratings of Hypera
Trading Rating : Investor Rating :
More Ratings
Latest news on HYPERA
06/29HYPERA : Ex-dividend day for
FA
03/30HYPERA : Ex-dividend day for
FA
03/09HYPERA : Slide show results
CO
03/09HYPERA : Annual results
CO
03/03HYPERA : annual earnings release
2019HYPERA : Ex-dividend day for
FA
2019HYPERA : Slide show Q3 results
CO
2019HYPERA : Ex-dividend day for
FA
2019HYPERA : Notice to the Market - Reduction of Relevant Stake
PU
2019HYPERA : Half-year results
CO
2019HYPERA : Ex-dividend day for
FA
2019HYPERA : Half-year report
CO
2019HYPERA : Notice to the Market - Change in the Management
PU
2019HYPERA : Material Fact - Share Repurchase
PU
2019HYPERA : Slide show Q1 results
CO
More news
News in other languages on HYPERA
06/29HYPERA : Ex-dividend day for
03/30HYPERA : Ex-dividend day for
03/03HYPERA : annual earnings release
03/03BOURSES ASIATIQUES : optimisme en Chine avant la réunion du G7, Tokyo sceptique
03/03HYPERA : Veröffentlichung des Jahresergebnisses
More news
Chart HYPERA
Duration : Period :
Hypera Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends HYPERA
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 15
Average target price 37,70 BRL
Last Close Price 32,40 BRL
Spread / Highest target 32,7%
Spread / Average Target 16,4%
Spread / Lowest Target -7,41%
EPS Revisions
Managers
NameTitle
Breno Toledo Pires de Oliveira Chief Executive Officer & Director
Álvaro Stainfeld Link Chairman
Adalmario Ghovatto Satheler do Couto Chief Financial Officer & IR Officer
Esteban Malpica Fomperosa Director
Bernardo Malpica Hernández Director
Sector and Competitors
1st jan.Capitalization (M$)
HYPERA-9.22%3 840
JOHNSON & JOHNSON-3.36%371 399
ROCHE HOLDING AG4.71%295 898
MERCK & CO., INC.-13.38%198 849
NOVARTIS AG-10.36%192 057
PFIZER, INC.-11.92%191 697